Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Kazuko, Nagase"'
Autor:
Toshiyuki Sato, Motoi Uchino, Jiro Takeuchi, Yutaro Fujihira, Kazuma Shimizu, Keiko Yokoyama, Soichi Yagi, Koji Kaku, Yusuke Takashima, Maiko Ikenouchi, Kentaro Kojima, Mikio Kawai, Kazuko Nagase, Koji Kamikozuru, Yoko Yokoyama, Tetsuya Takagawa, Hiroki Ikeuchi, Kenji Watanabe, Shinichiro Shinzaki
Publikováno v:
Clinical Nutrition. 42:722-731
Autor:
Kenji Watanabe, Tadakazu Hisamatsu, Hiroshi Nakase, Kazuko Nagase, Minoru Matsuura, Nobuo Aoyama, Taku Kobayashi, Hirotake Sakuraba, Kaoru Yokoyama, Masakazu Nishishita, Motohiro Esaki, Fumihito Hirai, Masakazu Nagahori, Sohachi Nanjo, Teppei Omori, Satoshi Tanida, Yoshihiro Yokoyama, Kei Moriya, Atsuo Maemoto, Osamu Handa, Naoki Ohmiya, Shinichiro Shinzaki, Shingo Kato, Hiroki Tanaka, Toshio Uraoka, Noritaka Takatsu, Hideo Suzuki, Kenichiro Takahashi, Junji Umeno, Yoshiyuki Mishima, Kenji Tsuchida, Mikihiro Fujiya, Sakiko Hiraoka, Shuji Yamamoto, Masayuki Saruta, Masanori Nojima, Akira Andoh
Publikováno v:
Gastroenterology. 162:S-1005
Autor:
Shiro Nakamura, Kazuko Nagase, Koji Nogami, Ken Fukunaga, Nobuyuki Hida, Yoko Yokoyama, Masaki Immured, Koji Kamikozuru, Misaki Nakamura, Mikio Kawai, Toshiyuki Sato
Publikováno v:
Cytotherapy. 16:821-825
Background aims In patients with inflammatory bowel disease infected with hepatitis B virus (HBV), immunosuppressive therapy required to suppress active inflammatory bowel disease may promote HBV reactivation. Methods A 27-year-old corticosteroid-nai
Autor:
Koichi Noguchi, Shiro Nakamura, Kazuko Nagase, Satoshi Yamamoto, Shenglan Wang, Yi Dai, Ken Fukunaga, Yongbiao Hao, Kazutoshi Hori, Shinichiro Kashiwamura, Junxiang Li, Hiroto Miwa, Yoko Kogure
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2014 (2014)
Evidence-Based Complementary and Alternative Medicine, Vol 2014 (2014)
Xilei san (XLS), a herbal preparation widely used in China for erosive and ulcerative diseases, has been shown to be effective in ulcerative colitis (UC). The present experiments were conducted to assess its efficacy and determine its mechanism of ac
Publikováno v:
Therapeutic Apheresis and Dialysis. 17:490-497
The aim of the present study was to assess patients' acceptance of therapeutic leukocytapheresis known as cytapheresis (CAP) for the treatment of an active flare of inflammatory bowel disease (IBD). A questionnaire was sent to 155 IBD patients who ha
Autor:
Nobuyuki Hida, Yoshio Ohda, Masaki Iimuro, Takayuki Matsumoto, Ken Fukunaga, Shiro Nakamura, Kazuko Nagase, Hiroto Miwa, Koji Kamikozuru, Yoko Yokoyama
Publikováno v:
Journal of Gastroenterology and Hepatology. 27:1808-1815
Background and Aim: Topical mesalamine or corticosteroid has shown efficacy in patients with ulcerative proctitis, but patients often become refractory to these interventions. Xilei San is a herbal preparation with evidence of anti-inflammatory effec
Autor:
Takayuki Matsumoto, Shiro Nakamura, Kazuko Nagase, Koji Kamokozuru, Ken Fukunaga, Hiroto Miwa, Yoko Yokoyama
Publikováno v:
Gut and Liver
Background/Aims Weekly granulocyte/monocyte adsorption (GMA) to deplete elevated and activated leucocytes should serve as a non-pharmacological intervention to induce remission in patients with ulcerative colitis (UC). This trial assessed the efficac
Autor:
Kyoichi Kato, Ken Fukunaga, Masaki Iimuro, Koji Yoshida, Takayuki Matsumoto, Nobuyuki Hida, Shiro Nakamura, Kazuko Nagase, Naohisa Takeda, Koji Kamikozuru, Kazutoshi Hori, Hiroto Miwa, Risa Kikuyama, Hiroki Ikeuchi, Yoshio Ohda, Yoko Yokoyama
Publikováno v:
Inflammatory Bowel Diseases. 18:1617-1623
Background: Infliximab (IFX) is effective for remission induction and maintenance of Crohn's disease (CD). This trial assessed the efficacy of scheduled maintenance IFX monotherapy to prevent postoperative CD recurrence. Methods: Thirty-one CD patien
Autor:
Koji Yoshida, Hiroto Miwa, Nobuyuki Hida, Kyoichi Kato, Yoko Yokoyama, Ken Fukunaga, Risa Kikuyama, Naohisa Takeda, Takayuki Matsumoto, Koji Kamikozuru, Shiro Nakamura, Kazuko Nagase, Masaki Iimuro, Yoshio Ohda
Publikováno v:
Journal of Clinical Apheresis. 26:326-331
Background: Leukocytapheresis (LCAP) is used as an adjunct therapy for patients with active ulcerative colitis (UC). Although, LCAP is routinely performed at 3,000 mL per session, we were interested to see that if this can be replaced with bodyweight
Autor:
Hiroto Miwa, Koji Yoshida, Yoko Yokoyama, S Nakamura, Koji Kamikozuru, Hiroki Ikeuchi, Kyouichi Kato, Kazuko Nagase, Takayuki Matsumoto, Ken Fukunaga, Masaki Iimuro, Risa Kikuyama, Yoshio Ohda, Nobuyuki Hida
Publikováno v:
Cytokine. 56:466-470
The CD4+CD25High T-cell phenotype has an essential immunoregulatory role, while the CD4+CD28null T-cell reflects immune pathology. We investigated the profiles of the CD4+CD25High and the CD4+CD28null T-cell phenotypes in patients with ulcerative col